Capricor Therapeutics Inc. (CAPR) is priced at $6.03 after the most recent trading session. At the very opening of the session, the stock price was $5.30 and reached a high price of $6.26, prior to closing the session it reached the value of $5.26. The stock touched a low price of $5.14.
Recently in News on August 31, 2020, Capricor Therapeutics to Present at The LD 500 Virtual Conference. LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Capricor Therapeutics (“Capricor”) (NASDAQ:CAPR), a clinical-stage biotechnology company focused on the development of first-in-class cell and exosome-based therapeutics for the treatment and prevention of diseases, today announced that it will be presenting at the LD 500 investor conference on Friday, September 4 at 9:20 AM ET / 6:20 AM PT. Linda Marbán, Ph.D, Chief Executive Officer, will be presenting to a live virtual audience. You can read further details here
Capricor Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.32 on 07/28/20, with the lowest value was $0.88 for the same time period, recorded on 03/12/20.
Capricor Therapeutics Inc. (CAPR) full year performance was 153.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Capricor Therapeutics Inc. shares are logging -51.06% during the 52-week period from high price, and 585.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.88 and $12.32.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1913646 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Capricor Therapeutics Inc. (CAPR) recorded performance in the market was 371.09%, having the revenues showcasing 25.36% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 115.11M, as it employees total of 16 workers.
Specialists analysis on Capricor Therapeutics Inc. (CAPR)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.33, with a change in the price was noted +4.25. In a similar fashion, Capricor Therapeutics Inc. posted a movement of +238.76% for the period of last 100 days, recording 5,003,811 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CAPR is recording 0.12 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.11.
Trends and Technical analysis: Capricor Therapeutics Inc. (CAPR)
Raw Stochastic average of Capricor Therapeutics Inc. in the period of last 50 days is set at 26.00%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 29.65%. In the last 20 days, the company’s Stochastic %K was 15.28% and its Stochastic %D was recorded 9.93%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 371.09%. Additionally, trading for the stock in the period of the last six months notably improved by 428.95%, alongside a boost of 153.36% for the period of the last 12 months. The shares increased approximately by 9.44% in the 7-day charts and went up by -24.25% in the period of the last 30 days. Common stock shares were driven by 25.36% during last recorded quarter.